• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

byYuchen DaiandMichael Pratte
July 4, 2022
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
Migraine collage: a woman with her eyes closed and soft arcs radiating from her temple, a glass of water and a sleep mask
Share on FacebookShare on TwitterShare on LinkedIn

1. Among US military veterans with posttraumatic headache and comorbid posttraumatic stress disorder symptoms, nonpharmacological interventions significantly improved headache-related disability and posttraumatic stress disorder symptom severity.

2. Cognitive behavioral therapy improved both headache and posttraumatic stress disorder symptoms, whereas cognitive processing therapy only successfully addressed posttraumatic stress disorder symptom severity.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There is currently minimal evidence on established treatments for comorbid posttraumatic stress disorder (PTSD) symptoms and posttraumatic headache (PTH). This randomized trial examined 2 nonpharmacological interventions for PTH in military veterans with persistent headache related to comorbid mild traumatic brain injury (mTBI) and clinical PTSD symptoms. Key outcomes included headache-related disability on the Headache Impact Test (HIT-6) and PTSD symptom severity on the PTSD Checklist for Diagnostic and Statistical Manual (PCL-5) assessed up to 6 months posttreatment. Among 193 combat veterans with PTH and PTSD symptoms, headache disability significantly improved with cognitive behavioral therapy (CBT) compared to usual treatment. Additionally, PTSD symptom severity significantly improved in patients receiving cognitive processing therapy compared to usual treatment, however, there was no significant effect of cognitive processing therapy on headache disability. A limitation of this study was the high dropout rate among combat veteran subjects resulting in increased effects of potential outliers.

Click to read the study in JAMA Neurology

Relevant Reading: A systematic review of dropout from psychotherapy for posttraumatic stress disorder among Iraq and Afghanistan combat veterans

RELATED REPORTS

Behavioral support does not improve patient-directed opioid tapering success

2 Minute Medicine Rewind April 13, 2026

In-Depth [randomized clinical trial]: This single center randomized trial included 193 post-9/11 US combat veterans (mean [SD] age, 39.7 [8.4] years; 167 [87%] male) with comorbid PTSD headache and symptoms from 2015-2019, with follow-up posttreatment at 3 and 6 months. Patients were randomized to 1 of 3 parallel groups: 1) CBT, 2) cognitive processing therapy or 3) treatment per usual for headache. Overall, the cohort reported severe baseline headache-related disability (mean [SD] HIT-6 score, 65.8 [5.6] points) and severe PTSD symptoms (mean [SD] PCL-5 score, 48.4 [14.2] points). For headache-related disability assessed on HIT-6, patients receiving CBT and cognitive processing therapy reported −3.4 (95%CI, −5.4 to −1.4; P < .01) and −1.4 (95%CI, −3.7 to 0.8; P = .21) points lower across aggregated posttreatment measurements vs usual care. For PTSD symptom severity assessed on PCL-5, patients receiving CBT and cognitive processing therapy reported −6.5 (95%CI, −12.7 to −0.3; P = .04) and −8.9 (95%CI, −15.9 to −1.9; P = .01) points lower vs usual care.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive behavioral therapy (CBT)headachepost-traumatic stress disorder (PTSD)
Previous Post

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

Next Post

Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]

RelatedReports

Opioid tapering collage: a calm bearded man beside paper steps holding three, two, then one white tablet, then none
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Mindfulness-based therapy associated with improvement in quality of life for PTSD patients
Weekly Rewinds

2 Minute Medicine Rewind April 13, 2026

April 13, 2026
Depression care collage: a calm woman in a linen shirt beside an empty speech bubble, a steaming teacup and a paper sunrise
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Migraine relief collage: a teenage girl resting on a pillow with a cool cloth on her forehead before drawn curtains
Neurology

Fremanezumab reduces migraine frequency in children and adolescents with episodic migraine

January 23, 2026
Next Post
ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]

COVID-19 collage: a young man in a surgical mask beside a virus particle, a folded mask and a hand sanitizer bottle

Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

Immune-related response criteria captures tumor response to therapy [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
  • Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis
  • Post-hoc CHARM analysis linked CIRARA with better functional outcomes in selected patients with severe stroke
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.